Journal of Viral Hepatitis (JVH)
Journal Descriptions
The Journal of Viral Hepatitis is a leading international, peer-reviewed medical journal dedicated to all scientific and clinical aspects of viral hepatitis. First published in 1994, it appears monthly and serves as a core forum for researchers, clinicians, and public health professionals involved in the study and management of hepatitis viruses including A, B, C, D and E. Its content encompasses cutting-edge basic research into viral replication, immunopathogenesis and host–virus interactions, as well as clinical investigations into diagnosis, therapeutic strategies, and outcomes. The journal also addresses epidemiological trends, prevention strategies including vaccination, and challenges such as antiviral resistance and global elimination goals. By publishing original research, systematic reviews, clinical trials, and expert commentaries, the Journal of Viral Hepatitis bridges laboratory science and patient care. It promotes evidence-based advances that inform clinical practice guidelines and public health policies. With an international editorial board and multidisciplinary readership spanning gastroenterology, infectious diseases, virology and immunology, the journal contributes to understanding disease mechanisms, improving patient care, and shaping global responses to viral hepatitis. This comprehensive scope makes it an authoritative resource for anyone seeking the latest developments in understanding and combating viral hepatitis across basic science and clinical domains.
Journal of Viral Hepatitis (JVH) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Virology, Infectious Diseases, Hepatology, basic and translational science, epidemiology, virology, immunology, clinical diagnosis, treatment and management of hepatitis caused by viral agents such as hepatitis A, E viruses, systematic reviews, short communications, clinical trials, and expert reviews that advance the understanding of viral infection mechanisms, host–virus interactions, immune responses, antiviral therapies, disease progression and outcomes, screening and prevention strategies , Online or Print , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1352-0504, E-ISSN: 1365-2893, Established: 1994, Impact Factor: 2.3
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE